background
acut
respiratori
infect
repres
seriou
public
health
issu
worldwid
virolog
aetiolog
influenza
like
ill
ili
remain
larg
unknown
develop
countri
studi
repres
first
attempt
characteris
viral
aetiolog
ili
bolivia
method
perform
santa
cruz
citi
januari
septemb
base
nasopharyng
swab
collect
nation
refer
laboratori
realtim
pcr
techniqu
viral
cultur
phylogenet
analys
result
sampl
posit
least
one
viru
influenza
virus
flu
flu
b
rhinovirus
coronavirus
hrsv
frequent
identifi
pattern
viral
infect
vari
accord
age
group
elucid
rate
highest
amongst
patient
yo
lowest
amongst
patient
yo
nearli
sampl
show
dual
viral
infect
epidemiolog
peak
associ
predomin
viru
gener
includ
infect
differ
virus
unexpectedli
frequenc
influenza
yo
popul
low
complet
hrsv
eclips
occur
genet
analys
indic
distinct
evolutionari
lineag
flu
flu
flu
b
cocircul
bolivia
studi
period
origin
central
north
america
europ
asia
australia
conclus
result
emphasis
requir
reinforc
epidemiolog
genet
followup
influenza
ili
bolivia
inform
prepar
vaccin
use
region
guid
vaccin
campaign
improv
medic
manag
patient
acut
respiratori
tract
infect
ari
repres
lead
caus
human
acut
ill
worldwid
import
contribut
factor
childhood
morbid
mortal
especi
age
besid
issu
bacteri
pneumonia
repres
frequent
caus
mortal
paediatr
popul
develop
countri
increas
interest
epidemiolog
character
influenza
like
ill
ili
predominantli
viral
aetiolog
first
ili
respons
larg
number
case
age
group
specif
high
frequenc
children
despit
frequent
associ
mild
clinic
present
medic
socioeconom
impact
enorm
second
proport
ili
associ
sever
clinic
evolut
adult
virus
put
caus
agent
third
case
communityacquir
pneumonia
particular
influenza
virus
rhinovirus
coronavirus
dual
viral
infect
common
larg
proport
children
evid
viralbacteri
coinfect
deciph
epidemiolog
pathophysiolog
link
viral
primari
infect
secondari
bacteri
superinfect
pneumonia
current
repres
major
challeng
improv
prevent
medic
manag
pneumonia
despit
import
term
morbid
well
infant
mortal
microbiolog
aetiolog
ari
repres
complex
yet
fulli
character
develop
countri
remain
larg
unknown
develop
countri
despit
recent
improv
due
prospect
studi
launch
follow
influenza
peru
ecuador
inform
ili
tropic
hispan
region
south
america
scarc
epidemiolog
remain
insuffici
characteris
perform
first
studi
ili
bolivia
cover
year
januari
septemb
viral
aetiolog
infect
investig
base
nasopharyng
swab
collect
nation
refer
laboratori
citi
santa
cruz
de
la
sierra
real
time
pcr
molecular
biolog
techniqu
viral
cultur
phylogenet
analys
number
sampl
could
analys
year
centro
nacion
de
enfermedad
tropical
cenetrop
determin
accord
logist
consider
total
attempt
build
repres
sampl
specimen
receiv
cenetrop
supposedli
poorli
repres
ili
gener
popul
santa
cruz
rather
examin
similar
number
sampl
age
group
allow
comprehens
aetiolog
analysi
age
class
final
sampl
equival
number
swab
age
class
per
class
slightli
lower
number
older
class
due
limit
number
sampl
receiv
cenetrop
age
group
expect
underrepres
year
old
yo
age
group
elig
sampl
receiv
overrepres
yo
age
group
addit
file
gener
characterist
distribut
case
present
tabl
gender
ratio
mf
histori
influenza
vaccin
clearli
show
limit
proport
popul
receiv
influenza
vaccin
particular
elderli
receiv
least
one
dose
influenza
vaccin
life
yo
age
group
sampl
test
posit
least
one
viru
tabl
influenza
virus
flu
flu
b
rhinovirus
hrv
coronavirus
hcov
respiratori
syncyti
viru
hrsv
frequent
identifi
pattern
viral
infect
vari
accord
age
group
figur
elucid
rate
highest
sampl
patient
age
yo
lowest
patient
yo
figur
b
sinc
sampl
origin
symptomat
patient
may
due
either
higher
preval
virus
test
higher
level
viral
shed
children
yo
age
group
display
specif
epidemiolog
characterist
major
hrsv
infect
infect
rate
remark
low
proport
influenza
infect
compar
yo
age
group
yo
age
class
yo
adenovirus
frequent
identifi
children
age
bocavirus
patient
age
hcov
although
present
age
group
preval
patient
yo
interestingli
metapneumovirus
hmpv
detect
children
adult
elev
rate
infect
yo
age
group
enterovirusesparechovirus
also
found
children
adult
rhinovirus
identifi
age
group
patient
year
age
nearli
sampl
show
dual
viral
infect
tabl
influenza
virus
rhinovirus
hcov
infect
detect
diagnos
situat
coinfect
coinfect
specif
frequent
case
adenovirus
despit
high
number
influenza
b
case
coinfect
note
rate
dual
infect
high
bocavirus
enterovirusesparechovirus
low
metapneumovirus
parainfluenzavirus
base
limit
number
case
median
age
differ
patient
singl
dual
infect
curv
posit
sampl
follow
sampl
test
figur
sampl
receiv
cenetrop
figur
peak
detect
match
peak
recept
sampl
global
follow
season
subtrop
pattern
ili
observ
bolivia
one
peak
austral
autumn
second
austral
winter
season
great
number
sampl
could
studi
allow
precis
follow
sever
peak
activ
correspond
mosaic
virus
includ
flu
b
hrsv
hrv
flu
hcov
number
sampl
studi
annual
lower
respect
still
suffici
elucid
main
peak
activ
major
incid
flu
flu
b
cocircul
varieti
virus
see
figur
epidemiolog
peak
gener
associ
predomin
summaris
figur
show
clear
epidemiolog
evolut
follow
flu
pandem
wave
influenza
infect
part
due
flu
associ
larg
number
flu
b
rhinoviru
infect
varieti
less
preval
virus
contrast
year
characteris
massiv
come
back
flu
low
number
flu
b
emerg
larg
number
hcov
infect
absenc
hrsv
infect
situat
chang
larg
number
flu
b
hrsv
infect
persist
signific
proport
rhinoviru
flu
infect
altogeth
provid
strike
pictur
move
infect
pattern
presum
model
herd
immun
epidemiolog
suscept
popul
complet
disappear
hrsv
infect
repres
specif
case
never
encount
author
europ
cell
cultur
isol
influenza
n
influenza
n
influenza
n
virus
obtain
eightseg
genom
sequenc
produc
flu
isol
genbank
access
number
flu
isol
genbank
access
number
partial
sequenc
segment
ha
na
ns
produc
flu
b
isol
genbank
access
number
correspond
sequenc
use
phylogenet
analys
influenza
b
virus
divid
two
antigen
lineag
sinc
frequent
cocircul
epidem
period
segment
reassort
strain
lineag
frequent
make
difficult
produc
robust
completegenom
phylogenet
analys
evolutionari
tree
reconstruct
align
ha
sequenc
show
ten
data
suggest
variant
belong
distinct
evolutionari
cluster
circul
simultan
south
america
influenza
season
inform
relev
optimis
formula
season
influenza
vaccin
order
provid
effici
protect
influenza
figur
altogeth
main
inform
aris
sever
evolutionari
lineag
cocircul
bolivia
pandem
wave
studi
repres
first
attempt
characteris
viral
aetiolog
ili
bolivia
first
south
america
postinfluenza
period
design
provid
repres
pictur
gener
bolivian
popul
sampl
origin
region
santa
cruz
item
discuss
ii
sampl
sent
cenetrop
expect
faith
repres
ili
region
santa
cruz
obviou
recruit
bias
clinic
sever
access
public
medic
care
iii
sampl
perform
object
obtain
equival
number
case
age
class
inform
obtain
therefor
analys
precaut
firstli
great
yeartoyear
variat
infect
epidemiolog
pattern
remind
epidemiolog
ili
studi
long
period
time
three
year
studi
would
provid
analys
separ
partial
view
situat
would
lead
erron
conclus
eg
absenc
hrsv
infect
bolivian
children
extrapol
data
analysi
period
expect
smooth
epidemiolog
jolt
extend
observ
period
would
undoubtedli
reveal
inform
virus
circul
low
rate
period
studi
eg
parechovirus
parainfluenzavirus
secondli
bolivia
includ
territori
divers
geograph
climat
ecolog
characterist
santa
cruz
locat
eastern
lowaltitud
area
humid
tropic
climat
whilst
la
paz
western
andean
highaltitud
area
colder
dryer
climat
may
explain
import
epidemiolog
differ
observ
citi
exemplifi
case
influenza
observ
limit
number
flu
infect
santa
cruz
whilst
paho
surveil
system
report
intens
circul
viru
la
paz
first
month
year
paho
surveil
websit
http
aispaho
orgphipvizedfluasp
larg
outbreak
occur
santa
cruz
see
figur
whilst
case
observ
la
paz
import
outbreak
observ
la
paz
santa
cruz
clearli
indic
epidemiolog
data
collect
santa
cruz
extrapol
easili
andean
region
bolivia
diverg
influenza
epidemiolog
pattern
accord
geograph
distribut
fine
document
previou
peruvian
studi
despit
fact
local
epidemiolog
ari
model
herd
immun
environment
factor
global
pictur
ari
aris
studi
conform
observ
differ
region
world
particular
choic
pathogen
test
seem
relev
sinc
rate
elucid
close
observ
franc
use
molecular
assay
author
person
data
ii
peak
detect
match
ili
epidemiolog
peak
iii
previou
studi
perform
brazil
differ
virus
identifi
current
studi
detect
confirm
circul
region
distribut
case
age
group
also
essenti
similar
report
elsewher
eg
ecuador
surpris
item
deserv
investig
extend
period
time
unusu
low
frequenc
influenza
infect
yo
age
group
complet
rsv
eclips
howev
precis
comparison
data
collect
south
america
often
difficult
eg
molecular
studi
ecuador
previou
larg
studi
peru
differ
period
investig
virus
detect
use
immunofluoresc
test
parechovirus
coronavirus
metapneumovirus
rhinovirus
test
genet
characteris
influenza
strain
indic
virus
belong
distinct
evolutionari
lineag
flu
flu
flu
b
cocircul
bolivia
interestingli
increas
number
influenza
sequenc
made
avail
sinc
phylogenet
reconstruct
reveal
one
hand
exist
south
american
evolutionari
cluster
influenza
strain
hand
complex
epidemiolog
relationship
rest
world
tree
suggest
circul
bolivia
studi
period
virus
origin
central
north
america
europ
asia
australia
studi
provid
first
systemat
broadspectrum
inform
regard
viral
aetiolog
ili
bolivia
continu
effort
need
accur
characteris
epidemiolog
ili
differ
region
countri
guid
vaccin
campaign
atrisk
popul
improv
medic
manag
patient
accord
previou
investig
perform
peru
result
emphasis
requir
reinforc
genet
followup
influenza
strain
circul
south
america
inform
prepar
vaccin
use
region
recruit
case
oper
follow
broad
spectrum
case
definit
ili
anybodi
fever
higher
associ
one
respiratori
symptom
identifi
ili
infect
elig
investig
use
nasopharyng
swab
sampl
hospit
health
centr
region
santa
cruz
sent
cenetrop
centro
nacion
de
enfermedad
tropical
santa
cruz
bolivia
diagnosi
januari
septemb
specimen
sampl
day
day
follow
clinic
onset
sent
laboratori
room
temperatur
use
univers
transport
media
kept
upon
recept
patient
legal
repres
gave
oral
consent
shipment
sampl
cenetrop
detect
respiratori
pathogen
provid
preliminari
report
viral
aetiolog
age
group
ie
inform
may
translat
easili
public
health
purpos
random
select
equival
number
sampl
oper
age
group
year
age
year
studi
aetiolog
identif
perform
use
taqman
probebas
realtim
pcr
rtpcr
protocol
sampl
spike
phage
use
intern
control
rna
respiratori
syncyti
virus
b
hrsv
hrsv
b
coronavirus
hcov
rhinoviru
hrv
adenovirus
hadv
enterovirus
parechovirus
hev
hpev
human
metapneumovirus
b
hmpv
human
bocavirus
hbov
sampl
provid
strong
posit
realtim
pcr
result
ct
influenza
b
virus
use
viru
isol
use
mdck
cell
standard
isol
protocol
addit
file
addit
strain
isol
cours
current
studi
influenza
viru
strain
isol
cenetrop
juneaugust
period
sequenc
reinforc
phylogenet
analys
see
sequenc
clarifi
supernat
influenza
b
posit
cell
cultur
extract
use
qiagen
instrument
viru
mini
kit
without
rna
carrier
qiagen
segment
influenza
viru
amplifi
singl
reaction
use
iii
onestep
rtpcr
system
taq
high
fidel
kit
univers
primer
obtain
influenza
b
viru
sequenc
use
similar
protocol
one
set
primer
amplifi
ha
na
ns
segment
anoth
set
newli
design
primer
ag
aagyasagcattttcttgtga
taaa
cacccacatyccaaacgt
amplifi
segment
pcr
product
purifi
nucleofast
pcr
plate
machrey
nagel
sequenc
use
ng
ion
torrent
technolog
briefli
dna
concentr
adjust
dsdna
br
assay
kit
fluoromet
librari
barcod
nt
fragment
built
use
diagenod
bioruptor
barcod
adapt
kit
ab
librari
life
technolog
clonal
amplif
perform
use
ion
templat
kit
ion
instrument
life
technolog
final
sequenc
perform
use
person
genom
system
ion
sequenc
kit
ion
chip
kit
life
technolog
